kr275.00
3.17%
Oslo, Oct 15, 04:19 pm CEST. Closed.
ISIN
NO0010159684
Symbol
MEDI

Medistim Target price 2026 - Analyst rating & recommendation

Medistim Classifications & Recommendation

Buy
88%
Hold
13%

Medistim Price Target

Target Price kr339.15
Price kr276.00
Potential
Number of Estimates 4
4 Analysts have issued a price target Medistim 2027 . The average Medistim target price is kr339.15. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 7 Analysts recommend Medistim to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Medistim stock has an average upside potential 2027 of . Most analysts recommend the Medistim stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Million kr ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

3 Analysts have issued a sales forecast Medistim 2026 . The average Medistim sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 kr700m 24.38%
2026
2027
2028

3 Analysts have issued an Medistim EBITDA forecast 2026. The average Medistim EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 kr221m 42.05%
2026
2027
2028

EBITDA Margin

2025 31.58% 14.21%
2026
2027
2028

3 Medistim Analysts have issued a net profit forecast 2026. The average Medistim net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 kr159m 53.34%
2026
2027
2028

Net Margin

2025 22.75% 23.28%
2026
2027
2028

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share kr ??? ???
??? ???
P/E ???
EV/Sales ???

3 Analysts have issued a Medistim forecast for earnings per share. The average Medistim EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 kr8.71 53.62%
2026
2027
2028

P/E ratio

Current 41.52 24.56%
2026
2027
2028

Based on analysts' sales estimates for 2026, the Medistim stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 9.30 37.37%
2026
2027
2028

P/S ratio

Current 9.42 36.70%
2026
2027
2028

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today